Is psychedelic drug therapy on track to become as ubiquitous as meditation?
To date, much of the clinical research on psychedelics has focused on their potential to treat acute mental health conditions, such as treatment-resistant depression. But scientists are also examining the drugs’ effects on so-called “healthy normal” populations — in other words, people who haven’t been diagnosed with an addiction or mental illness.
In one 2018 study, researchers reported that healthy people who took psilocybin, the active ingredient in magic mushrooms, reported a general increase in feelings of gratitude, forgiveness and interpersonal closeness — along with a positive change in their sense of spirituality and purpose in life. For many, those effects lingered even six months later.
Original Article (CBC):
Is psychedelic drug therapy on track to become as ubiquitous as meditation?
Artwork Fair Use: NASA/NOAA/GSFC/Suomi NPP/VIIRS/Norman Kuring